Blog

Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem … – Wall Street Journal

Bioheart Announces Agreement With Invitrx to License Adipose Derived Stem
Wall Street Journal
Invitrx Therapeutics is a biotechnology company specializing in the culture and engineering of adult stem cells, innovative products and therapies that are used in aesthetics, wound closure, and healing, as well as, plastic and reconstructive surgery

…read more    

2013-09-23 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.